INSIGHTS ON DRUG DEVELOPMENT
-
Thunderstruck By Antibody-Drug Conjugates
Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.
-
Complementing Routine Peptide Monitoring
Discover how to enhance your peptide analysis by integrating UV and mass spectral data into a single, streamlined workflow to boost data confidence and lab efficiency.
-
ITC: Unveiling Its Role And Importance In Drug Design
Explore how Isothermal Titration Calorimetry empowers drug discovery, as well as learn about ITC fundamentals, how to eliminate weak candidates, and how to optimize development decisions.
-
Preclinical Evaluation Of Antifibrotics In COVID-Induced Fibrosis Model
Advancing the development of effective antifibrotic therapies requires urgent investment in clinically relevant, IND-enabling preclinical models to address the growing burden of fibrotic diseases.
-
Optimizing Upstream Process Development To Increase mAb Titers3/28/2025
Uncover how we were able to help a client develop an efficient upstream process for a novel monoclonal antibody (mAb), resulting in a more than 100% increase in titers.
-
Merck Process Transfer And Scale-Up Of Batch Protein A6/30/2025
Explore cost-saving innovations in purification using a system that achieves consistent product quality and yield while significantly reducing resin use and enhancing large-scale efficiency.
-
Beyond SOPs: Assessing Quality Of CDMOs5/16/2024
When choosing a CDMO partner, it is essential to prioritize quality. Discover how the right partner can instill confidence in the safety and effectiveness of your pharmaceutical products.
-
Facilitate Handling Of Bulk Powders With Dry Granulation8/11/2025
Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.
-
Biofluorescent Particle Counters Are Gaining Momentum4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
DRUG DEVELOPMENT SOLUTIONS
-
Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.
-
Preconfigured protocols and custom assay workflows simplify microplate data acquisition and analysis
SoftMax® Pro Software for Windows 10 is designed to provide the simplicity, flexibility and power required for advanced data analysis. It provides ready-to-run protocols, analysis algorithms, and 21 different curve fit options.
-
Next-generation fluorescent imaging solution for the assurance of monoclonality and automated confluence across diverse cell types
Demonstrating that cell lines are monoclonal – or that a gene was edited as expected – can be a time-consuming and highly-subjective process when relying on conventional technologies. The CloneSelect® Imager and CloneSelect® Imager FL are a high-throughput automated solutions for imaging and analyzing mammalian cells. Tracking the formation of a colony from a single cell is effortless as barcoded plates are tracked over time. Automated acquisition and analysis provides accurate, objective, and consistent results.
-
A scalable, high-throughput, high-content screening solution with 7-channel high-intensity laser light source and machine learning capabilities.
-
Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Explore more about its vital role in modern immunology innovation.